Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-68 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-68 |
filingDate |
2001-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18d623e8916a1a34d7775ad78e33fce9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16e3317d5622e7f960cf8eb169b12da5 |
publicationDate |
2002-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-0218363-A2 |
titleOfInvention |
3-phenyl-propanoic acid derivatives as protein tyrosine phosphatase inhibitors |
abstract |
Compound of formula (I) or therapeutically acceptable salts thereof, are protein tyrosine kinase PTP1B inhibitors. Preparation of the compounds, compositions containing the compounds, and treatment of diseases using the compounds are disclosed. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9394285-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8889730-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7582773-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7141596-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7718377-B2 |
priorityDate |
2000-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |